| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,910 |
1,863 |
$177K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,843 |
2,740 |
$155K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
2,007 |
1,621 |
$65K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
725 |
714 |
$37K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
395 |
395 |
$33K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
2,409 |
2,403 |
$22K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
221 |
221 |
$18K |
| 96127 |
|
1,319 |
1,262 |
$17K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
145 |
145 |
$13K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,136 |
1,126 |
$13K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
146 |
145 |
$12K |
| 90461 |
|
299 |
299 |
$11K |
| 99177 |
|
248 |
248 |
$7K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
220 |
216 |
$5K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
51 |
51 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
312 |
311 |
$4K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
113 |
111 |
$4K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
133 |
132 |
$3K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
137 |
137 |
$3K |
| 92558 |
|
186 |
186 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
201 |
132 |
$2K |
| 0002A |
|
43 |
43 |
$2K |
| 0071A |
|
40 |
40 |
$2K |
| 0001A |
|
22 |
22 |
$1K |
| 99051 |
|
57 |
56 |
$943.92 |
| 0154A |
|
14 |
14 |
$642.32 |
| 99173 |
|
25 |
25 |
$555.50 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
30 |
30 |
$473.06 |
| A7005 |
Administration set, with small volume nonfiltered pneumatic nebulizer, non-disposable |
17 |
17 |
$136.00 |
| 85018 |
|
51 |
50 |
$113.80 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
17 |
17 |
$41.65 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
13 |
13 |
$21.00 |